FOXD3 and breast carcinoma: FOXD3-AS1 has been shown to have predictive value and functional roles in various diseases, including breast cancer, cervical cancer, nasopharyngeal carcinoma, cerebral ischemia/reperfusion injury, cardiomyocyte injury, allergic rhinitis, and so on [15–17, 27, 28].